tiprankstipranks
Trending News
More News >
Clinuvel Pharmaceuticals Limited (CLVLF)
:CLVLF
US Market
Advertisement

Clinuvel Pharmaceuticals (CLVLF) Financial Statements

Compare
41 Followers

Clinuvel Pharmaceuticals Financial Overview

Clinuvel Pharmaceuticals 's market cap is currently $391.78M. The company's EPS TTM is $0.28711478; its P/E ratio is 16.87; and it has a dividend yield of 0.42%. Clinuvel Pharmaceuticals is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is $0.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 95.02MAU$ 88.18MAU$ 78.32MAU$ 65.72MAU$ 47.98M
Gross ProfitAU$ 79.14MAU$ 80.45MAU$ 50.59MAU$ 46.62MAU$ 35.20M
Operating IncomeAU$ 45.73MAU$ 48.01MAU$ 40.91MAU$ 33.08MAU$ 26.70M
EBITDAAU$ 57.20MAU$ 51.86MAU$ 46.37MAU$ 35.08MAU$ 26.57M
Net IncomeAU$ 36.17MAU$ 35.64MAU$ 30.60MAU$ 20.88MAU$ 24.73M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 224.11MAU$ 183.87MAU$ 156.81MAU$ 121.51MAU$ 82.69M
Total AssetsAU$ 271.75MAU$ 231.12MAU$ 194.52MAU$ 144.81MAU$ 108.57M
Total DebtAU$ 528.53KAU$ 879.78KAU$ 999.87KAU$ 1.26MAU$ 1.30M
Net DebtAU$ -223.58MAU$ -182.99MAU$ -22.87MAU$ -26.15MAU$ -35.84M
Total LiabilitiesAU$ 30.94MAU$ 28.11MAU$ 29.89MAU$ 19.25MAU$ 9.83M
Stockholders' EquityAU$ 240.81MAU$ 203.01MAU$ 164.63MAU$ 125.56MAU$ 98.74M
Cash Flow
Free Cash FlowAU$ 40.80MAU$ 31.48MAU$ 35.88MAU$ 39.44MAU$ 18.41M
Operating Cash FlowAU$ 41.10MAU$ 37.05MAU$ 36.91MAU$ 39.87MAU$ 19.26M
Investing Cash FlowAU$ -47.72MAU$ -29.03MAU$ -1.03MAU$ -434.44KAU$ -854.33K
Financing Cash FlowAU$ -2.94MAU$ -3.57MAU$ -2.24MAU$ -1.50MAU$ -1.48M
Currency in AUD

Clinuvel Pharmaceuticals Earnings and Revenue History

Clinuvel Pharmaceuticals Debt to Assets

Clinuvel Pharmaceuticals Cash Flow

Clinuvel Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis